Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Non-cash Items: 2017-2024

  • Rhythm Pharmaceuticals' Non-cash Items rose 16.33% to $4.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.6 million, marking a year-over-year increase of 16.33%. This contributed to the annual value of $4.6 million for FY2024, which is 16.33% up from last year.
  • As of Q4 2024, Rhythm Pharmaceuticals' Non-cash Items stood at $4.6 million, which was up 16.33% from $3.9 million recorded in Q4 2023.
  • Rhythm Pharmaceuticals' 5-year Non-cash Items high stood at $74.0 million for Q4 2022, and its period low was $3.2 million during Q4 2021.
  • Moreover, its 3-year median value for Non-cash Items was $4.6 million (2024), whereas its average is $27.5 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first spiked by 2,202.24% in 2022, then slumped by 94.68% in 2023.
  • Rhythm Pharmaceuticals' Non-cash Items (Quarterly) stood at $3.2 million in 2021, then soared by 2,202.24% to $74.0 million in 2022, then slumped by 94.68% to $3.9 million in 2023, then increased by 16.33% to $4.6 million in 2024.
  • Its Non-cash Items was $4.6 million in Q4 2024, compared to $3.9 million in Q4 2023 and $74.0 million in Q4 2022.